http://opendata.unex.es/recurso/educacion/universidad/personal/2bc5d3b88cad32618a0491727194ec53-eva-maria-penas-lledo
Relations
- teach:teacherOf
- ou:tienePublicacion
- A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances
- A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts
- ABCB1 gene polymorphisms and violent suicide attempt among survivors
- Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers
- Anterior cingulate activity in bulimia nervosa: A fMRI case study
- Antipsychotic drugs and QTc prolongation: The potential role of CYP2D6 genetic polymorphism
- Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms
- Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: Relevance for treatment with antipsychotic drugs
- Association of anger with bulimic and other impulsive behaviours among non-clinical women and men
- Borderline personality and bulimia nervosa: A clinical study
- CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards
- CYP2C9 gene and susceptibility to major depressive disorder
- CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy
- CYP2D6 and the severity of suicide attempts
- CYP2D6 ethnic variability in hispanics
- CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas
- CYP2D6 genetic polymorphism and psychiatry patients' hospitalization period
- CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans
- CYP2D6 polymorphism and mental and personality disorders in suicide attempters
- CYP2D6 polymorphism in patients with eating disorders
- CYP2D6 polymorphism: Implications for antipsychotic drug response, schizophrenia and personality traits
- CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients
- CYP2D6 variation, behaviour and psychopathology: Implications for pharmacogenomics-guided clinical trials
- CYP2D6-1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers
- Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting
- Clinical implementation of pharmacogenetics and personalized drug prescription based on e-health: The MedeA initiative
- Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugs
- Clinical use of pre-emptive pharmacogenetic programmes
- Cognitive behaviour therapy response and dropout rate across purging and nonpurging bulimia nervosa and binge eating disorder: DSM-5 implications
- Development of a HPLC method for the determination of losartan urinary metabolic ratio to be used for the determination of CYP2C9 hydroxylation phenotypes
- Differences in cognitive behavioral therapy dropout rates between bulimia nervosa subtypes based on drive for thinness and depression
- Differential study of the complete and subclinical presentations of bulimia nervosa
- Eating attitudes and the use of alcohol, tobacco, and exercise among male and female adolescents
- Eating disorder symptoms and CYP2D6 variation in cuban healthy females: A report from the Ibero-American network of pharmacogenetics
- Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions
- Effect of non-alcohol beer on anxiety: Relationship of 5-HIAA
- Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
- Erratum: CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients (Molecular Psychiatry (2013) 18 (266))
- Erratum: Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment (Molecular Psychiatry, (2017), 22, 8, (1155-1163), 10.1038/mp.2016.204)
- Erratum: Schizophrenia and tobacco smoking in a Spanish psychiatric hospital (Schizophrenia Research (2002) 58 (323-327) PII: S09209964010032)
- Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: The CEIBA cocktail
- Excessive exercise in anorexia nervosa and bulimia nervosa: Relation to eating characteristics and general psychopathology
- Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans
- High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina
- High frequency of CYP2D6 ultrarapid metabolizers in Spain: Controversy about their misclassification in worldwide population studies
- High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders
- High risk of polydipsia and water intoxication in schizophrenia patients
- History of anorexia nervosa in bulimic patients: Its influence on body composition
- Impact of cytochrome P450 genes on suicide attempt and risk
- Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele
- Increased use of second generation antipsychotic drugs in primary care: Potential relevance for hospitalizations in schizophrenia patients
- Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy
- Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations
- Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain
- Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations
- Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 ibero-and native Americans: RIBEF-CEIBA consortium report on population pharmacogenomics
- Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations
- Lessons from Cuba for global precision medicine: CYP2D6 genotype is not a robust predictor of CYP2D6 ultrarapid metabolism
- Lifetime obesity in patients with eating disorders: Increasing prevalence, clinical and personality correlates
- Liver enzyme abnormalities during antipsychotic treatment: A case report of risperidone-associated hepatotoxicity
- Losartan hydroxylation phenotype in an Ecuadorian population: Influence of CYP2C9 genetic polymorphism, habits and gender
- Low frequency of CYP2D6 poor metabolizers among schizophrenia patients
- MDR-1 genotypes and quetiapine pharmacokinetics in healthy volunteers
- Metabolic phenotype prediction from genotyping data: A bottleneck for the implementation of pharmacogenetics in drug development and clinical practice
- Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: Influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms
- Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285
- No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients [2]
- Pattern of birth and eating attitudes in young adults: Failure to replicate in a warmer climate
- Pattern of birth in restrictive and bulimic eating disorders
- Personality changes in bulimia nervosa after a cognitive behaviour therapy
- Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence
- Pharmacogenetic research activity in Central America and the Caribbean: A systematic review
- Pharmacogenetic studies of suicide: Potential relevance of main polymorphic CYPs and ABCB1
- Pharmacogenetics in Latin American populations: Regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders
- Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine
- Pharmacogenetics of clinical response to risperidone
- Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity
- Pharmacogenetics: ethnicity, treatment and health in Latin American populations
- Pharmacogenomics and personality: Role of CYP2D6 and implications for psychopathology
- Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014)
- Predictors of early change in bulimia nervosa after a brief psychoeducational therapy
- Prevalence of polydipsia and water intoxication in psychiatric inpatients
- Psychopathology of bulimia nervosa: A multidimensional model
- Reduced completed suicide rate in Hungary from 1990 to 2001: Relation to suicide methods
- Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers
- Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers
- Relationship between the CYP2C9 IVS8-109A>T polymorphism and high losartan hydroxylation in healthy Ecuadorian volunteers
- Relationships between objective physical characteristics and the use of weight control methods in adolescence: A mediating role for eating attitudes?
- Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population
- Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients
- Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital
- Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population
- Risk for self-reported anorexia or bulimia nervosa based on drive for thinness and negative affect clusters/dimensions during adolescence: A three-year prospective study of the TChAD cohort
- Schizophrenia and tobacco smoking in a Spanish psychiatric hospital [1]
- Schizophrenia and tobacco smoking in a Spanish psychiatric hospital
- Specific eating disorder clusters based on social anxiety and novelty seeking
- Subtype criteria for bulimia nervosa: Short-versus long-term compensatory behaviors
- Subtyping eating disordered patients along drive for thinness and depression
- Subtyping undergraduate women along dietary restraint and negative affect
- The genetics of eating disorders
- Use of pharmacogenetics in bioequivalence studies to reduce sample size: An example with mirtazapine and CYP2D6
- VEGF-related polymorphisms identified by GWAS and risk for major depression
- Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes
- ou:perteneceAGrupoInvestigacion
- ou:adscritoACentro
- ou:imparteDocenciaEnArea
- ou:adscritoADepartamento
Inverse Relations
Inverse Blank Nodes
